Skip to content
Chat on WhatsApp
Tirzepatide

Incretin-Pathway Peptides

Tirzepatide

A modified GIP-sequence peptide with GLP-1 receptor activity, sealed as a lyophilized vial for receptor research.

  • 39-amino-acid class, GIP-based sequence
  • Lipid-linked side chain
  • Sealed vials, 5mg to 100mg

Research use only

Tirzepatide is a modified GIP-sequence-based peptide with GLP-1 receptor activity and a lipid-linked side chain, built on the 39-amino-acid class shared with retatrutide. It anchors the incretin-pathway section of this catalog alongside that entry.

This peptide is presented as a research reference for receptor pharmacology, peptide stability studies, and analytical method development. The molecular weight and formula shown on this page describe the peptide as supplied in lyophilized form.

Vials are sealed after freeze-drying and available across the widest size range in this catalog, from 5mg through 100mg. Batch documentation for a specific lot is confirmed by inquiry.

Purity≥99% by HPLC
CAS number2023788-19-2
Molecular weight4813 g/mol
Molecular formulaC225H348N48O68
Material class39-amino-acid peptide
AppearanceWhite to off-white lyophilized powder
Available vial sizes5mg · 10mg · 20mg · 30mg · 40mg · 50mg · 60mg · 100mg
DocumentationBatch documentation confirmed on request

← Back to the catalog